Power Morcellator Update: Bernstein Liebhard LLP Notes Insurer’s Decision to End Coverage for Uterin

The Firm is evaluating morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcoma and other cancers due to uterine morcellation. New York, New York (PRWEB) August 04, 2014 The controversy surrounding the cancer risks associated with power morcellators (http://www.injurybeacon.com/power-morcellator/) continues to grow, as Bernstein Liebhard LLP notes that one of the country’s largest Blue Cross/Blue Shield insurers has announced it will end coverage for uterine morcellation as of September 1, 2014. According to a report from Reuters, Pennsylvania-based
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories